Global Ethylenediaminetetraacetic Acid (EDTA) Tubes Market, By Capacity (<2ml, 2ml-4ml, -6ml, and >6ml), Method (Manual Blood Collection and Automated Blood Collection), End-User (Hospitals, Diagnostics Centers, Blood Banks and Others), End User (Hospitals, Trauma Centres, Ambulatory Surgical Centres and Other), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2030.
Ethylenediaminetetraacetic Acid (EDTA) Tubes Market Analysis and Size
The market growth is increasing due to the high expenditure in healthcare by several governments in numerous regions and the rising use in the understanding of the immune system. Demand for the product is possible to increase because of the increasing need for storage solutions made from high-grade raw materials for different serological tests. Ethylenediaminetetraacetic acid (EDTA) tubes are of great use in blood clothing because of the presence of irreversibly chelates calcium ion in EDTA tubes that create new opportunities for the market
Data Bridge Market Research analyses that the ethylenediaminetetraacetic acid (EDTA) tubes market which is USD 0.72 billion in 2022, would rocket up to USD 1.28 billion by 2030, and is expected to undergo a CAGR of 7.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Ethylenediaminetetraacetic Acid (EDTA) Tubes Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Capacity (<2ml, 2ml-4ml, -6ml, and >6ml), Method (Manual Blood Collection and Automated Blood Collection), End-User (Hospitals, Diagnostics Centers, Blood Banks and Others), End User (Hospitals, Trauma Centres, Ambulatory Surgical Centres and Other), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Terumo Corporation (Japan), BD (U.S.), Pfizer Inc. (U.S.), Medtronic (Ireland), SEKISUI CHEMICAL CO., LTD. (Japan), Narang Medical Limited (U.S.), Mitra Industries (India), Nipro Europe Group Companies (Japan), Greiner Bio-One International GmbH (Austria), Quest Diagnostics Incorporated (U.S.), McKesson Medical-Surgical Inc (U.S.), Aptaca Spa. (Italy)
|
|
Market Opportunities
|
|
Market Definition
Ethylenediaminetetraacetic acid (ETDA) tubes are small tubular containers widely used in the healthcare industry for blood donor screening, blood hematology determination, and immunohematology testing. They are also used in scientific laboratories and other sectors. Ethylenediamine tetraacetic acid (EDTA) is a polyprotic acid with four carboxylic acid groups and two amine groups with lone-pair electrons that chelate calcium and numerous other metal ions.
Ethylenediaminetetraacetic Acid (EDTA) Tubes Dynamics
Drivers
- Increasing Usage of EDTA in Laboratories and Histopathology
EDTA has been suggested as the standard anticoagulant of choice for hematological testing as it allows the best preservation of different cellular components and morphology of blood cells. The huge expansion in laboratory test volume and complexity in the past few decades has enlarged the spectrum of applications for this anticoagulant, which can be used to increase blood for several traditional and innovative tests. The immense use of EDTA for measuring cytokines, protein and peptides, and cardiac markers is also well known, as they help in protection of labile molecules provided by this anticoagulant
Opportunities
- Increasing Use of EDTA in Protein Purification
Ethylenediaminetetraacetic acid (EDTA) is commonly used in protein purification to eradicate contaminating divalent cations and hinder protease activity. Any sort of solution was tested wherein a precalculated amount of EDTA was slowly added to the collection tubing. The elution was then collected into the buffer containing EDTA. It would chelate any stripped nickel ions from the column and reduce protein-protein self-interactions, thus decreasing the risk of aggregation. This is how EDTA is used in protein purification.
Restraints/Challenges
- Error in Platelets Count
The increasing error in platelets count by using EDTA tubes is hampering the market growth. It is well known to cause erroneous results of platelet counts by different automated hematological analysers resulting in low platelets counts. Thus, this hampers the patient test results. Thus, it restricts the market growth.
This ethylenediaminetetraacetic acid (EDTA) tubes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ethylenediaminetetraacetic acid (EDTA) tubes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Ethylenediaminetetraacetic Acid (EDTA) Tubes Market Scope
The ethylenediaminetetraacetic acid (EDTA) tubes market is segmented on the basis of capacity, method, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Capacity
- <2ml
- 2ml-4ml
- -6ml
- >6ml
Method
- Manual Blood Collection
- Automated Blood Collection
End-user
- Hospitals
- Diagnostics Centers
- Blood Banks
- Others
Ethylenediaminetetraacetic Acid (EDTA) Tubes Regional Analysis/Insights
The ethylenediaminetetraacetic Acid (EDTA) tubes market is analyzed and market size insights and trends are provided by capacity, method and end-user as referenced above.
The countries covered in the ethylenediaminetetraacetic Acid (EDTA) tubes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the ethylenediaminetetraacetic acid (EDTA) tubes market because of the well-established healthcare infrastructures setup in countries such as Canada and the U.S.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of increasing number of patients having blood and platelet tests.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The ethylenediaminetetraacetic acid (EDTA) tubes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for ethylenediaminetetraacetic Acid (EDTA) tubes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the ethylenediaminetetraacetic acid (EDTA) tubes market. The data is available for historic period 2011-2021.
Competitive Landscape and Global Ethylenediaminetetraacetic Acid (EDTA) Tubes Share Analysis
The ethylenediaminetetraacetic Acid (EDTA) tubes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to ethylenediaminetetraacetic acid (EDTA) tubes market.
Some of the major players operating in the ethylenediaminetetraacetic acid (EDTA) tubes market are:
- Terumo Corporation (Japan)
- BD (U.S.)
- Pfizer Inc. (U.S.)
- Medtronic (Ireland)
- SEKISUI CHEMICAL CO., LTD. (Japan)
- Narang Medical Limited (U.S.)
- Mitra Industries (India)
- Nipro Europe Group Companies (Japan)
- Greiner Bio-One International GmbH (Austria)
- Quest Diagnostics Incorporated (U.S.)
- McKesson Medical-Surgical Inc(U.S)
- Aptaca Spa. (Italy)
SKU-